Bios, a neural engineering startup originally based out of Cambridge, U.K. and now with an additional newly opened R&D office in Montreal, Canada, has raised $4.5 million in seed funding. The company is developing a “neural interface” that combines advances in hardware, big data, and machine learning/AI, which it’s hoped can be used to develop new cutting-edge treatments on organs and nerve systems throughout the body.

The round is led by Real Ventures, AME Cloud

Read More At Article Source | Article Attribution